A study protocol for a double-blinded, randomised, placebo-controlled trial on the use of encapsulated FMT for reducing the side effects of HSCT: the HSCT-BIOME study.
Saved in:
| Title: | A study protocol for a double-blinded, randomised, placebo-controlled trial on the use of encapsulated FMT for reducing the side effects of HSCT: the HSCT-BIOME study. |
|---|---|
| Authors: | Li A; School of Biomedicine, The University of Adelaide, Adelaide, Australia.; Supportive Oncology Research Group, Precision Cancer Medicine, The South Australian Health and Medical Research Institute, Adelaide, Australia., Costello SP; BiomeBank, Adelaide, Australia.; Adelaide Medical School, The University of Adelaide, Adelaide, Australia., Bryant RV; BiomeBank, Adelaide, Australia.; Department of Gastroenterology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Adelaide, Australia., Haylock-Jacobs S; BiomeBank, Adelaide, Australia.; Adelaide Medical School, The University of Adelaide, Adelaide, Australia., Haifer C; Department of Gastroenterology, St Vincent's Hospital Sydney, Sydney, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, Australia., Lee C; Department of Haematology, The Royal Adelaide Hospital, SA Health, Adelaide, Australia., Yeung D; Department of Haematology, The Royal Adelaide Hospital, SA Health, Adelaide, Australia., Giri P; Department of Haematology, The Royal Adelaide Hospital, SA Health, Adelaide, Australia., Blunt D; Department of Haematology, The Royal Adelaide Hospital, SA Health, Adelaide, Australia., Bowen JB; School of Biomedicine, The University of Adelaide, Adelaide, Australia., Ryan FJ; College of Medicine and Public Health, Flinders University, Adelaide, Australia., Yong A; Department of Haematology, The Royal Adelaide Hospital, SA Health, Adelaide, Australia., Wardill HR; School of Biomedicine, The University of Adelaide, Adelaide, Australia. Hannah.wardill@adelaide.edu.au.; Supportive Oncology Research Group, Precision Cancer Medicine, The South Australian Health and Medical Research Institute, Adelaide, Australia. Hannah.wardill@adelaide.edu.au.; Level 5S, SAHMRI, North Terrace, Adelaide, 5000, SA, Australia. Hannah.wardill@adelaide.edu.au. |
| Source: | BMC cancer [BMC Cancer] 2025 Apr 10; Vol. 25 (1), pp. 656. Date of Electronic Publication: 2025 Apr 10. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2407 |
|---|---|
| DOI: | 10.1186/s12885-025-14057-4 |
